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Abstract: myo-Inositol plays a key role in signal trans-
duction and osmotic regulation events in the CNS. De-
spite the known high concentrations of inositol in the
human CNS, relatively little is known about its distribution
within the different cell types. In this report, inositol ho-
meostasis was studied in NT2-N cells, a unique cell cul-
ture model of human CNS neurons. Differentiation of
precursor NT2 teratocarcinoma cells into NT2-N neurons
by means of retinoic acid treatment resulted in an in-
crease in inositol concentration from 24 to 195 nmol/mg
of protein. After measurement of intracellular water
spaces, inositol concentrations of 1.6 and 17.4 mM were
calculated for NT2 and NT2-N cells, respectively. The
high concentrations of inositol in NT2-N neurons could be
explained by (1) an increased uptake of inositol (3.7 vs.
1.6 nmol/mg of protein/h, for NT2-N and NT2 cells, re-
spectively) and (2) a decreased efflux of inositol (1.7%/h
for NT2-N neurons vs. 9.0%/h for NT2 cells). Activity of
inositol synthase, which mediates de novo synthesis of
inositol, was not detected in either cell type. The obser-
vation that CNS neurons maintain a high intracellular
concentration of inositol may be relevant to the regulation
of both phosphoinositide signaling and osmotic stress
events in the CNS. Key Words: Neuronal differentia-
tion—Inositol efflux—Osmotic stress—Phlorizin—Inosi-
tol uptake—Inositol synthase.
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myo-Inositol serves at least two major physiological
roles in the CNS. First, it is a precursor of phospholipids
such as the 3-phosphoinositides, which have been impli-
cated in adhesion, growth, vesicular trafficking, and cell
survival (Toker and Cantley, 1997), as well as the quan-
titatively major polyphosphoinositides, including phos-
phatidylinositol 4-phosphate and phosphatidylinositol
4,5-bisphosphate, which mediate signal transduction
(Berridge and Irvine, 1989) and cytoskeletal rearrange-
ment (Carpenter, 1996). Second, free inositol is involved
in volume regulation during persistent osmotic stress
(Nakanishi et al., 1989; Isaacks et al., 1994; Strange et
al., 1994; Reeves and Cammarata, 1996). Whereas acute
osmotic regulation is mediated by changes in electrolyte
balance, chronic osmotic stress is countered by changes
in the concentration of organic osmolytes such as inositol
(Gullans and Verbalis, 1993).
Disorders of neuronal inositol metabolism are be-
lieved to lead to neurological and psychiatric disease. For
example, the pathogenesis of Down syndrome could be
related to the expression of multiple gene copies of the
Na1/myo-inositol transporter and a high concentration of
inositol in the fetal CSF (Berry et al., 1995; Acevedo et
al., 1997). Increased cerebral inositol concentrations also
result from persistent hypernatremia (Lee et al., 1994),
the rapid correction of which can lead to fatal cerebral
edema (Gullans and Verbalis, 1993). Conversely, condi-
tions such as diabetic peripheral neuropathy (Yorek et
al., 1994; Karihaloo et al., 1997; Sima et al., 1997) and
some cases of neural tube defect (Cockroft, 1988; Greene
and Copp, 1997) have been linked to a deficiency of
inositol and an attenuation of phosphoinositide signaling.
It has been speculated that the therapeutic effectiveness
of Li1 in the treatment of bipolar disorder derives from
its ability to deplete inositol stores and consequently to
inhibit inositol lipid synthesis in those neurons that ex-
hibit abnormally high rates of phosphoinositide turnover
(Berridge et al., 1989; Einat et al., 1998).
Despite the clinical significance of neuronal inositol
homeostasis, the concentration of inositol in CNS neu-
rons remains uncertain. Relatively high concentrations of
inositol have been reported for giant neurons of Deiters’
nucleus (Sherman et al., 1977) and the molecular layer of
cerebellar flocculus (Godfrey et al., 1982). In contrast,
based on experiments with dissected layers of cerebellar
cortex (Stewart et al., 1969), whole sections of cerebral
cortex (Godfrey, 1989), and neuroblastoma and glioma
cells (Glanville et al., 1989), it has been concluded that
concentrations of inositol in glia may exceed those in
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neurons. Thus, inositol stores in neurons could poten-
tially be more susceptible than those in glia to depletion
by agents such as Li1. An additional consideration is that
both inositol uptake (Inoue et al., 1996; Patishi et al.,
1996) and phosphoinositide turnover (Hwang et al.,
1990) are reported to be highly variable in different
regions of the brain. Hence, inositol concentration and
metabolism may be similarly regionally diverse.
To address a lack of information regarding inositol
concentrations in CNS neurons and the mechanisms
whereby those concentrations are attained, inositol ho-
meostasis has been investigated in NT2-N neurons.
NT2-N cells are derived from the human teratocarci-
noma cell line NT2, which is induced to irreversibly
differentiate to a postmitotic neuronal phenotype by
means of retinoic acid treatment (Andrews, 1984; An-
drews et al., 1984; Pleasure et al., 1992). NT2-N cells
have a highly polarized and distinctly neuronal morphol-
ogy, characterized by a single axon and multiple den-
drites. In addition, NT2-N neurons express many CNS
neuron-specific proteins such as neurofilament subunits
(Lee and Andrews, 1986), neural cell adhesion mole-
cules and neuronal microtubule-associated proteins
(Pleasure et al., 1992), NMDA receptors (Younkin et al.,
1993), choline acetyltransferase (Zeller and Strauss,
1995), and tyrosine hydroxylase (Iacovitti and Stull,
1997). These cells also express functional phosphoino-
sitide signaling proteins such as M3 and M5 muscarinic
receptors, Gq, and phospholipase C-b (Wolf et al., 1995;
Squires et al., 1996). NT2-N neurons are thus nearly
identical to primary neurons in culture by numerous
morphological, immunocytochemical, biochemical, and
electrophysiological criteria. The present results indicate
that after differentiation of NT2 stem cells to NT2-N
neurons, the concentration of inositol increases;10-
fold, and that this increase can be accounted for by
increased uptake and decreased efflux of inositol. A
preliminary account of part of this study has been re-
ported previously (Novak et al., 1998).
MATERIALS AND METHODS
Materials
myo-[2-3H]Inositol (80 Ci/mmol) was obtained from Amer-
sham (Arlington Heights, IL, U.S.A.).D-[6-3H]Glucose 6-phos-
phate (60 Ci/mmol) was from American Radiolabeled Chemi-
cals (St. Louis, MO, U.S.A.). 3-O-[3H]Methyl-D-glucose (60
Ci/mmol), 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-
propanone (phloretin), phloretin 29-b-D-glucoside dihydrate
(phlorizin), bis(trimethylsilyl)trifluoroacetamide, alltrans-reti-
noic acid, uridine, 5-fluoro-29-deoxyuridine, cytosineb-D-ar-
abinofuranoside, NAD,myo- and scyllo-inositol, and myo-
inositol monophosphate phosphohydrolase (inositolm no-
phosphatase; EC 3.1.3.25) were purchased from Sigma
Chemical (St. Louis, MO, U.S.A.). Powdered Dulbecco’s mod-
ified Eagle’s medium (DMEM), 0.25% (wt/vol) trypsin, 103
trypsin-EDTA [0.5% (wt/vol) trypsin, 5.3 mM EDTA], 13
Versene (0.2 g/L of EDTA in phosphate-buffered saline), 503
penicillin/streptomycin (5,000 U/ml of penicillin G sodium and
5,000mg/ml of streptomycin sulfate), and Hanks’ balanced salt
solution were from GIBCO (Grand Island, NY, U.S.A.). Fetal
calf serum was obtained from BioWhittaker (Walkersville,
MD, U.S.A.). Matrigel basement membrane matrix and poly-
D-lysine hydrobromide were from Collaborative Biomedical
Products (Bedford, MA, U.S.A.). Tissue culture supplies were
obtained from Corning Glass Works (Corning, NY, U.S.A.)
and Sarstedt (Newton, NC, U.S.A.). Coomassie Plus and bicin-
choninic acid protein assay reagents were from Pierce (Rock-
ford, IL, U.S.A.). UniverSol-ES liquid scintillation cocktail
was obtained from ICN (Costa Mesa, CA, U.S.A.). Dowex-1
resin (100–200 mesh; X8 formate) was from Bio-Rad Labora-
tories (Hercules, CA, U.S.A.). High-performance TLC plates
(0.20 mm) were obtained from Merck (Darmstadt, Germany).
En3Hance surface autoradiography enhancer was from Du
Pont/New England Nuclear (Boston, MA, U.S.A.). One-month-
old male Sprague–Dawley rats were purchased from Harlan
(Indianapolis, IN, U.S.A.). Rat cerebellar granule cells, L929
mouse fibroblast cells, and 1321N1 human astrocytoma cells
were gifts from Dr. M. E. Gnegy (University of Michigan), Dr.
M. D. Uhler (University of Michigan), and Dr. R. K. Palmer
(University of North Carolina), respectively.
Cell culture
NT2 stem cells (passages 50–80) were grown in 75-cm2
tissue culture flasks containing DMEM supplemented with
10% (vol/vol) fetal calf serum and (during retinoic acid treat-
ment) 13 penicillin/streptomycin. NT2 cells were differenti-
ated into the neuronal phenotype (NT2-N) as previously de-
scribed (Pleasure et al., 1992). In brief, NT2 cells were treated
with 10 mM retinoic acid twice per week for 5 weeks. After
retinoic acid treatment, cells were rinsed with 13 Versene,
detached from culture flasks with 0.25% (wt/vol) trypsin, and
replated into 225-cm2 flasks (replate I). Two days later, cells
were rinsed with Hanks’ balanced salt solution and treated with
13 trypsin-EDTA. Flasks were then struck repeatedly to re-
move NT2-N cells, which were replated into 6-cm dishes
previously coated with 10mg/ml poly-D-lysine and 1:36 Ma-
trigel in DMEM (replate II). NT2-N cells were seeded at a
density of 2.5–5.03 106 cells/dish. For the first 3 weeks after
replate II, NT2-N cells were maintained in DMEM supple-
mented with 10% (vol/vol) fetal calf serum, 13 penicillin/
streptomycin, 10mM 5-fluoro-29-deoxyuridine, 10mM uridine,
and 1 mM cytosine b-D-arabinofuranoside. After 3 weeks,
NT2-N cells were maintained in conditioned medium obtained
from replate I. NT2-N cells were used for experiments between
4 and 5 weeks after replate II. NT2 cells used for inositol efflux
experiments were frequently plated on dishes previously coated
with poly-D-lysine and Matrigel to improve adherence to the
substratum; this treatment had no observable effect on inositol
transport characteristics. Both NT2 and NT2-N cells were
grown at 37°C in a humidified atmosphere of 90% air and
10% CO2.
Rat cerebellar granule cells were prepared essentially as
described by del Rı´o et al. (1998). These cells and SH-SY5Y
human neuroblastoma, 1321N1 human astrocytoma, and L929
mouse fibroblast cells were maintained in DMEM supple-
mented with 10% (vol/vol) fetal calf serum as described above.
Inositol-free SH-SY5Y cells were grown as described above,
except that cells were maintained in inositol-free DMEM sup-
plemented with dialyzed fetal calf serum.
Inositol mass
Cells were washed with a modified Puck’s D1 solution
(Honegger and Richelson, 1976), detached from culture flasks
or dishes by either scraping or incubation with D1 containing
13 trypsin-EDTA, and centrifuged at 1,000g for 1 min.
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Similar values for inositol content were obtained with each
procedure. Rats were killed by decapitation. Cell or rat tissue
was lysed in 1 ml of water and ultrasonicated with a Sonic
Dismembrator 60 (Fisher Scientific, Hampton, NH, U.S.A.).
Proteins were determined and 0.25–1.0 mg of lysate protein
was extracted with 1.5 ml of CHCl3/CH3OH (1:2) and 1 ml of
CHCl3. scyllo-Inositol (500 nmol) was added to some extracts
as an internal standard. Extracts were centrifuged at 2,400g for
5 min. The upper aqueous phase was blown free of CH3OH
under N2, stored at280°C for 1 h, and lyophilized overnight.
Samples were resuspended in 50ml of pyridine and 50ml of
bis(trimethylsilyl)trifluoroacetamide and heated at 70°C for
2 h. Samples were stored in a desiccator overnight and centri-
fuged at 2,400g for 5 min. Inositol mass was determined with
an HP 5890A gas chromatograph (Hewlett-Packard, Palo Alto,
CA, U.S.A.) fitted with an SP 2250 capillary column (Supelco,
Bellefonte, PA, U.S.A.). Samples (2ml) were injected with the
injector temperature at 220°C and the oven temperature at
130°C. After 6 min, the oven temperature was ramped at
5°C/min to 155°C. The temperature was held for 5 min and
ramped at 25°C/min to 240°C. The temperature was again held
for 5 min and then returned to the initial temperature. The
detector temperature was 350°C. An HP 3396A integrator
(Hewlett-Packard) was used to calibrate signal intensity for
myo- and scyllo-inositol, which eluted as single peaks with
retention times of 11.8 and 11.2 min, respectively.
Intracellular water space
Intracellular water spaces were measured essentially as pre-
viously described by Kletzien et al. (1975). NT2 and NT2-N
cells, attached to 6-cm dishes, were washed with 53 2 ml of
buffer A without glucose (142 mM NaCl, 5.6 mM KCl, 2.2 mM
CaCl2, 3.6 mM NaHCO3, 1 mM MgCl2, and 30 mM HEPES,
pH 7.4) and incubated with various concentrations of 3-O-
[3H]methyl-D-glucose at 37°C for 30 min. Cells were then
washed with 53 2 ml of ice-cold buffer A without glucose
containing 0.1 mM phloretin and lysed with 23 1 ml of
ice-cold 6% (wt/vol) trichloroacetic acid. Lysates were trans-
ferred to test tubes on ice and centrifuged at 2,400g for 5 min
at 4°C. Intracellular 3-O-[3H]methyl-D-glucose in 1 ml of su-
pernatant was determined by liquid scintillation spectroscopy
after the addition of 10 ml of UniverSol scintillation fluid.
Inositol uptake
A modification of the method of Batty et al. (1993) was used
to determine inositol uptake. NT2 and NT2-N cells, attached to
6-cm dishes, were washed with 43 2 ml of buffer A (142 mM
NaCl, 5.6 mM KCl, 2.2 mM CaCl2, 3.6 mM NaHCO3, 1 mM
MgCl2, 30 mM HEPES, and 5.6 mM D-glucose, pH 7.4) and
allowed to equilibrate in 2.85 ml of the same buffer at 37°C for
30 min. Reactions were initiated after the addition of 150ml of
various concentrations of [3H]inositol (5 mCi/mmol) and al-
lowed to proceed at either 0 or 37°C for 1 h. To terminate the
reactions, the buffer was rapidly aspirated and the cells were
washed with 53 2 ml of ice-cold buffer A containing 1 mM
inositol and lysed with 23 1 ml of ice-cold 6% (wt/vol)
trichloroacetic acid. Lysates were transferred to test tubes on
ice and centrifuged at 2,400g for 5 min at 4°C. Radioactivity
in the supernatant was determined as previously described. The
pellet was dissolved in a solution of 5% (wt/vol) sodium
dodecyl sulfate and 0.1M NaOH and analyzed for protein. In
experiments to study the effect of hypertonicity, cells were
maintained for 24 h in either isotonic (350 mOsm) medium or
medium made hypertonic (500 mOsm) by the addition of NaCl.
When the Na1 dependence of inositol uptake was examined,
cells were washed and incubated in either buffer A or Na1-free
buffer A (which contained 142 mM choline chloride instead of
NaCl and 3.6 mM KHCO3 instead of NaHCO3).
In some experiments, the uptake of inositol into NT2-N cells
was monitored in prolonged incubations. Under these condi-
tions, NT2-N cells, attached to 6-cm dishes, were incubated
at 37°C with conditioned medium containing 10mCi/ml myo-
[2-3H]inositol for up to 96 h. Reactions were terminated and
radioactivity associated with supernatant (cytosol) fraction was
determined as described above. To determine the incorporation
of [3H]inositol into phospholipids, 1 ml of water, 1 ml of
CHCl3, and 1.5 ml of CHCl3/CH3OH (1:2) were added to the
tissue pellets, and lipids were extracted and analyzed for3H-
labeled phosphoinositides as described by Fisher et al. (1984).
The remaining pellet was dissolved in a solution of 5% (wt/vol)
sodium dodecyl sulfate and 0.1M NaOH and analyzed for
protein content.
Inositol efflux
NT2 and NT2-N cells, attached to 6-cm dishes, were incu-
bated at 37°C for 1 h in medium containing 20mCi/ml myo-
[2-3H]inositol (short-term labeling) or 18 h in medium contain-
ing 10 mCi/ml myo-[2-3H]inositol (long-term labeling). After
preincubation, the cells were washed with 33 2 ml of buffer
A and incubated in 4 ml of buffer A at 37°C. Aliquots of
extracellular medium (50ml) were periodically removed and
centrifuged at 7,800g for 5 min to remove cell debris and
radioactivity was determined. To terminate the reactions, the
medium was rapidly aspirated and the cells washed with 33 2
ml of ice-cold buffer A. Cells were lysed with 23 1 ml of
ice-cold 6% (wt/vol) trichloroacetic acid and water-soluble
radioactivity determined as previously described. Total water-
soluble radioactivity present initially in the cells was calculated
as the sum of that recovered in the extracellular medium and
that remaining in the lysate at the end of the assay. Efflux at any
given time was then expressed as the ratio of radioactivity
present in extracellular medium to total [3H]inositol.
Inositol synthase
L-myo-Inositol-1-phosphate synthase (inositol synthase; EC
5.5.1.4) activity was measured by a modification of the proce-
dure of Culbertson et al. (1976). Rats were killed by decapita-
tion and brain or testis suspended in ice-cold homogenization
buffer [50 mM Tris-HCl and 0.02% (wt/vol) NaN3, pH 7.4] at
a final concentration of 0.5 g/ml. Tissue was homogenized in
glass homogenizers at 4°C. One 75-cm2 flask of NT2 cells and
eight to ten 6-cm dishes of NT2-N cells (;1 mg of protein)
were incubated with D1 containing 13 trypsin-EDTA. Cells
were removed, resuspended in 0.1 ml of homogenization
buffer, and triturated. Both rat homogenates and cell tissue
lysates were transferred to microfuge tubes and centrifuged at
19,500 g for 15 min at 4°C. The supernatants were then
removed and proteins determined. To initiate the reaction, 10
ml of supernatant (;100–200mg of protein) was added to 10
ml of incubation buffer (28 mM NH4Cl, 5.4 mM MgCl2, 150
mM Tris acetate, pH 7.4, 1.6 mM NAD, 4 mM D-glucose
6-phosphate, and 1 mCi/mlD-[6-3H]glucose 6-phosphate), and
the reaction was allowed to proceed at 37°C for 1 h. Reactions
were terminated by placing reaction tubes in a boiling water
bath for 5 min. Control samples were boiled for 5 min before
the addition of incubation buffer. Inositol monophosphatase (10
ml of 0.25 U/ml; 1 U produces 1.0mmol/min of phosphate at
pH 7.4 and 37°C) was added and each sample incubated at
37°C for 1 h to convert inositol 1-phosphate to inositol. The
sample volume was increased to 0.5 ml by the addition of
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water, and 0.5 ml of Dowex-1 resin was added to bind anionic
compounds. The resin was washed and pelleted by centrifuga-
tion and the supernatant, which contained inositol, was taken to
dryness either by lyophilization or vacuum centrifugation. The
supernatants were then resuspended in 40ml of unlabeled
inositol (5 mg/ml) and 20ml was spotted onto preheated TLC
plates. The plates were run twice for 6–12 h in a tank equili-
brated with 120 ml of propanol/pyridine/water (3:1:1, by vol-
ume), sprayed with En3Hance, and exposed to x-ray film for
2–4 days. The band comigrating with an authentic [3H]inositol
standard was scraped and radioactivity was determined.
Data analysis
Results shown represent mean6 SEM values for the num-
ber (n) of independent experiments performed. Duplicate or
triplicate values were obtained for each parameter measured.
Student’s two-tailedt tests were used to evaluate the statistical
differences between the means of paired or unpaired sets of
data.
RESULTS
Teratocarcinoma stem cells (NT2) differentiate into
CNS neurons (NT2-N) after retinoic acid treatment
Previous reports (Andrews, 1984; Andrews et al.,
1984) have described the retinoic acid-mediated differ-
entiation of NT2 teratocarcinoma cells to postmitotic
NT2-N neurons. Before differentiation, NT2 stem cells
showed the rapid proliferation, lack of contact inhibition,
and amorphous phenotype characteristic of cancer cells
(Fig. 1A). After 5 weeks of treatment with 10mM
retinoic acid, however, the cells ceased to divide and
began to aggregate. After selective replating and 1 week
of treatment with mitotic inhibitors, the cell population
was enriched for NT2-N neurons, which propagated neu-
rites as residual NT2 cells died (Fig. 1B). Three weeks
later, cultures of NT2-N neurons were obtained, orga-
nized into an interconnected network of prominent gan-
glia that elaborated processes resembling axons and den-
drites (Fig. 1C). These cultures have previously been
shown to be.95% pure by immunocytochemical crite-
ria (Lee and Andrews, 1986; Pleasure et al., 1992).
Neuronal differentiation of NT2 cells results in an
increased intracellular concentration of inositol
To assess the effect of neuronal differentiation on
inositol homeostasis, inositol concentrations within NT2
and NT2-N cells were compared. NT2-N neurons con-
tained approximately eight times the mass of inositol
present in NT2 stem cells (195 vs. 24 nmol/mg of pro-
tein; Table 1). As both cell types were maintained in the
presence of similar concentrations of extracellular inosi-
tol (;100 mM), these data indicate that neuronal differ-
entiation is accompanied by a substantial accumulation
of inositol. By comparison, the concentration of inositol
in primary cultures of rat cerebellar granule cells was
;20% of that in NT2-N neurons. SH-SY5Y human
neuroblastoma cells, a frequently used model of PNS
neurons, contained approximately one-half the concen-
tration of inositol present in NT2-N cells. As observed
previously for SK-N-SH neuroblastoma cells (Stubbs
and Agranoff, 1993), the concentration of inositol in
SH-SY5Y cells could be further reduced to 16 nmol/mg
of protein by growth in inositol-free medium for 1–4
weeks. Inositol concentrations in 1321N1 human astro-
cytoma cells and L929 mouse fibroblast cells were also
lower than those in NT2-N cells. The concentrations of
FIG. 1. Phase-contrast photomicrographs illustrating the mor-
phological changes that occur during retinoic acid-mediated
differentiation of NT2 cells and subsequent treatment of NT2-N
cells with mitotic inhibitors. A: Untreated NT2 teratocarcinoma
stem cells. B: Individual NT2-N neurons, 7 days after replate II as
described in Materials and Methods. C: NT2-N ganglia, 28 days
after replate II. Bar 5 0.1 mm.
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inositol in gray and white matter of rat brain were ap-
proximately one-third those in NT2-N neurons, whereas
those of rat testis and liver were very low (,11 and 2%,
respectively, of that in NT2-N neurons).
To obtain a more physiologically relevant measure-
ment of intracellular concentrations of inositol, the intra-
cellular water spaces in NT2 and NT2-N cells were
determined. Cells were incubated in the presence of
increasing extracellular concentrations of 3-O-[3H]-
methyl-D-glucose and intracellular concentrations moni-
tored at equilibrium. A plot of these two parameters
yields a line whose slope is the volume of intracellular
water with respect to protein (data not shown). Determi-
nation of water space by this method requires that 3-O-
methyl-D-glucose not be metabolized or actively trans-
ported, and these assumptions were validated by the
linearity of the plot and its extrapolation through the
origin (Kletzien et al., 1975). The water spaces inside
NT2 and NT2-N cells were 15.16 0.1 and 11.26 0.1
ml/mg of protein, respectively (n5 3). Based on these
data, the intracellular concentrations of inositol in NT2
stem cells and NT2-N neurons were calculated to be 1.6
and 17.4 mM, respectively.
Neuronal differentiation of NT2 cells is
accompanied by an increased uptake of inositol
Of the possible mechanisms underlying the high con-
centrations of inositol in NT2-N neurons, inositol uptake
is the most thoroughly characterized (Yorek et al., 1986;
Fruen and Lester, 1991; Wiesinger, 1991; Batty et al.,
1993). Uptake of [3H]inositol into NT2 and NT2-N cells
was determined during short-term (1 h) incubations (Fig.
2). Under these conditions, uptake was linear with time
from 5 min onward at concentrations of inositol up to
500mM (data not shown). Dose–response curves and the
associated Eadie–Hofstee plot (Fig. 2A) indicated a max-
imal velocity of inositol uptake (Vmax) of 1.6 nmol/mg of
protein/h into NT2 cells, which increased to 3.7 nmol/mg
of protein/h after neuronal differentiation. The EC50 val-
ues for inositol uptake were 70 and 36mM for NT2 and
NT2-N cells, respectively. Because of the limited avail-
ability of NT2-N cells, changes in inositol uptake after
differentiation were routinely examined at two selected
concentrations of inositol, i.e., 50mM, a value close to
the EC50, and 250mM, a value that approximates the
Vmax(Fig. 2B). At both concentrations of inositol, uptake
into NT2-N cells was approximately double that ob-
served for NT2 cells (p , 0.001).
In most cells, high-affinity inositol uptake is mediated
by an Na1/myo-inositol transporter. Batty et al. (1993)
and others have described this transporter on the basis of
its Na1 dependence and competitive inhibition by phlo-
rizin. In addition, transcription of the Na1/myo-inositol
transporter is up-regulated during conditions of chronic
hypertonicity (Nakanishi et al., 1989; Isaacks et al.,
1994). The uptake of [3H]inositol into NT2 and NT2-N
FIG. 2. Uptake of myo-inositol into NT2 and NT2-N cells. A: NT2
(E) or NT2-N (F) cells, adherent to 6-cm dishes, were washed
four times with buffer and incubated with [3H]inositol (5 mCi/
mmol) at the concentrations indicated at either 0 or 37°C for 1 h.
Cells were then washed five times with ice-cold buffer containing
1 mM inositol and lysed with trichloroacetic acid. Lysates were
centrifuged and radioactivity present in supernatants deter-
mined. Results shown are the differences between mean 6 SEM
values of triplicate samples at 0 and 37°C for NT2 or NT2-N cells
assayed on the same day in a single experiment. Uptake at 0°C
was typically 5–10% of uptake at 37°C. Where error bars are not
shown, they fell within the symbol. SEM was calculated as the
square root of [(SEM1)2 1 (SEM2)2], where SEM1 and SEM2 are
the standard errors of the mean for inositol uptake at 0 and 37°C.
Inset: Eadie–Hofstee plot of dose–response data. B: NT2 or
NT2-N cells were incubated with 50 or 250 mM [3H]inositol as
described in A. Results shown are mean 6 SEM values for four
to eight separate experiments. ***Different from NT2 cells, p
, 0.001.





NT2 stem cells 24.56 1.9 (10)
NT2-N neurons 195.26 22.6 (8)
Rat cerebellar granule cells 41.16 9.8 (3)
SH-SY5Y human neuroblastoma cells 111.76 12.1 (5)
SH-SY5Y human neuroblastoma cells (IF) 16.11.6 (5)
1321N1 human astrocytoma cells 76.28.1 (3)
L929 mouse fibroblasts 37.06 7.3 (3)
Cerebral cortical gray matter 60.96 5.5 (3)
Cerebral cortical white matter 79.56 0.6 (3)
Testis 21.26 1.1 (3)
Liver 4.66 0.7 (3)
Cell or tissue lysates were prepared as described in Materials and
Methods and inositol mass was determined by gas chromatography.
SH-SY5Y cells (IF) were maintained in inositol-free medium for 4
weeks. Results shown are mean6 SEM values for the number of
separate experiments indicated in parentheses.
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cells was almost completely (.90%) Na1-dependent at
50 and 250mM concentrations of inositol in both cell
types (Table 2). The inclusion of phlorizin caused a
dose-dependent inhibition of uptake in both NT2 and
NT2-N cells consistent with competitive antagonism of
the transporter. Furthermore, maintenance of both NT2
and NT2-N cells in hypertonic medium (500 mOsm) for
24 h stimulated inositol uptake to a similar degree (two-
to threefold). These data imply that an Na1/myo-inositol
transporter is involved in high-affinity uptake in both cell
types, and that the characteristics of inositol uptake are
not affected by neuronal differentiation. However, the
two cell types differed with respect to changes in inositol
mass after hypertonic exposure. Although hypertonicity
resulted in an increase in inositol concentration in NT2
cells consistent with the increase in uptake (2826 40%
of control, n5 3), little or no increase in inositol con-
centration was observed in NT2-N neurons (1206 8%
of control, n5 4; different from NT2 cells,p , 0.01).
The concentration of inositol present in NT2-N neu-
rons (17.4 mM) is 150–200-fold higher than that of the
extracellular medium (;100 mM). To determine how
readily the intracellular pool of inositol in NT2-N cells
could exchange with extracellular inositol, the kinetics of
[3H]inositol uptake into the neurons were monitored in
prolonged incubations (1–96 h; Fig. 3). These long-term
incubation assays were feasible in NT2-N neurons be-
cause of the postmitotic state of the cells. The uptake of
label into both the water-soluble and the lipid fractions of
the neurons was curvilinear and approached a plateau by
96 h (Fig. 3A and B, respectively), although the appear-
ance of radioactivity in the water-soluble fraction pre-
ceded the incorporation of label into the lipid fraction.
By 96 h, the cells had attained a specific activity of;300
dpm/pmol inositol, a value similar to the specific activity
of inositol calculated to be present in the extracellular
medium. Equilibrium labeling of the inositol lipid pool
was achieved by;48 h, at which time;1% of the
water-soluble radioactivity could be recovered in the
TABLE 2. Characterization of inositol uptake in NT2 and NT2-N cells
Characteristic Inositol (mM) Phlorizin (mM)
% of control uptake
NT2 NT2-N
Na1 dependence 50 — 95.26 1.0 97.46 0.9a
250 — 91.76 1.2 93.66 1.9a
Phlorizin inhibition 50 0.2 47.56 4.3 52.36 5.3a
50 1.0 20.66 0.8 21.36 0.4a
Hypertonic stimulation 250 — 279.96 39.9 226.06 23.3a
NT2 or NT2-N cells, adherent to 6-cm dishes, were incubated with [3H]inositol for 1 h, then lysed with
trichloroacetic acid and centrifuged. Radioactivity in the lysate supernatant was determined as described in
Materials and Methods. For Na1-dependence assays, cells were incubated in either buffer A or Na1-free buffer
A (which contained choline chloride instead of NaCl). For hypertonic stimulation assays, cells were maintained
for 24 h in either isotonic (350 mOsm) medium or medium made hypertonic (500 mOsm) by the addition of
NaCl. Results shown are mean6 SEM values for three separate experiments. Control values for inositol uptake
in NT2 cells were 2.26 0.4 and 3.26 0.5 nmol/mg of protein/h (n5 4–5) at inositol concentrations of 50 and
250 mM, respectively. The corresponding values for NT2-N cells were 3.86 0.5 and 5.46 0.3 nmol/mg of
protein/h (n5 4–6).
a Not different from NT2 cells,p . 0.05.
FIG. 3. Long-term labeling of NT2-N cells with [3H]inositol.
NT2-N cells, adherent to 6-cm dishes, were incubated at 37°C
with medium containing 10 mCi/ml [3H]inositol for 1–96 h. Cells
were then washed five times with ice-cold buffer containing 1
mM inositol and lysed with trichloroacetic acid. Lysates were
centrifuged and radioactivity present in supernatants deter-
mined. Lipids were extracted from pellets as described in Ma-
terials and Methods. A: Water-soluble radioactivity. Values were
determined by quantification of radioactivity in lysate superna-
tants. B: Radioactivity in phospholipids. Values were determined
by quantification of radioactivity in organic fractions. C: Ratio of
radioactivity present in phospholipid relative to that present in
water-soluble fraction. Results shown are mean 6 SEM values
for three separate experiments. Where error bars are not shown,
they fell within the symbol.
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phosphoinositide fraction (Fig. 3C). More than 95% of
the radioactivity found in lipid after 24 h was in the form
of phosphatidylinositol, with the remainder associated
with the polyphosphoinositides (data not shown).
Neuronal differentiation of NT2 cells is associated
with a decreased efflux of inositol
Changes in inositol efflux from NT2 and NT2-N cells
were also evaluated as a potential mechanism whereby
changes in inositol concentration could be effected. After
prelabeling cells for 1 h with [3H]inositol, the efflux of
label was monitored for 6 h. After an initial lag period of
;30 min, efflux of label from NT2 stem cells proceeded
at an approximately linear rate of 9.06 1.8%/h (n5 3),
whereas efflux from NT2-N neurons was significantly
lower (1.76 0.1%/h, n5 3; different from NT2 cells,p
5 0.01; Fig. 4A). The kinetics of [3H]inositol efflux from
NT2 and NT2-N cells prelabeled with [3H]inositol for
18 h were comparable to those obtained for the shorter
prelabeling period and in NT2 cells proceeded at four to
five times the rate of that observed for NT2-N neurons
(Fig. 4B). More than 95% of NT2 and NT2-N cells
excluded the vital dye trypan blue throughout the course
of the efflux period, a result that indicates that a reduc-
tion in cell viability did not account for the differences in
the release of [3H]inositol between the two cell types.
Neither NT2 nor NT2-N cells exhibit measurable
inositol synthase activity
An additional potential mechanism to explain the ob-
served increases in inositol concentration after neuronal
differentiation is an increased de novo synthesis of ino-
sitol mediated byL-myo-inositol-1-phosphate synthase
(inositol synthase, EC 5.5.1.4). This enzyme, which cat-
alyzes the cyclization ofD-glucose 6-phosphate toL-
inositol 1-phosphate, has been found in the seminiferous
tubules of testis (Eisenberg, 1967) and in the capillary
endothelium of brain (Wong et al., 1987). Cell lysates
and rat tissue homogenates were incubated with [3H]glu-
cose 6-phosphate, and [3H]inositol 1-phosphate thus pro-
duced was converted to [3H]inositol, which was then
separated by TLC. As anticipated, inositol synthase ac-
tivity was readily measured in rat testis, whereas the
activity in brain (0.126 0.06 nmol/mg of protein/h, n
5 3) was ,8% of that present in testis (1.576 0.35
nmol/mg of protein/h, n5 5). No production of [3H]-
inositol was detected when equivalent amounts of either
NT2 or NT2-N lysates were assayed under the same
conditions. These data suggest that de novo synthesis of
inositol plays little or no role in the increased intracel-
lular inositol concentration in NT2-N neurons.
DISCUSSION
myo-Inositol is required for phosphoinositide synthe-
sis and for osmotic regulation within the CNS. Conse-
quently, its cellular concentrations and proper disposition
within the CNS can be critical to neurological and be-
havioral function. It is well established that concentra-
tions of inositol in brain are much higher than those in
plasma (5–50 mM vs. 0.05–0.1 mM, respectively; Pal-
mano et al., 1977; Sherman et al., 1977; Stokes et al.,
1983; Pouwels and Frahm, 1998) as well as in other
organs, but the role that neurons play in the maintenance
of these substantial inositol stores has yet to be defined.
This report is the first, to our knowledge, in which the
concentration of inositol in a pure population of cultured
CNS neurons has been directly measured. It has been
suggested that inositol is primarily (Glanville et al.,
1989) or even exclusively (Brand et al., 1993) to be
found in glia. The present results indicate, however, that
neurons, as has been reported for glia (Isaacks et al.,
1994), are able to maintain high intracellular concentra-
tions of inositol, a conclusion in agreement with earlier
observations of Sherman et al. (1977). The concentra-
tions of inositol in NT2-N neurons (195 nmol/mg of
protein) exceeded those found in astrocytoma cells (76
nmol/mg of protein), rat brain gray and white matter
(;70 nmol/mg of protein), and human brain (60
nmol/mg of protein; Stokes et al., 1983). However, the
concentration of inositol present in NT2-N neurons (195
nmol/mg of protein; 17.4 mM) is consistent with the
FIG. 4. Efflux of myo-inositol from NT2 and NT2-N cells. A:
Short-term prelabeling of cells with [3H]inositol. NT2 (E) or
NT2-N (F) cells, adherent to 6-cm dishes, were incubated with
medium containing 20 mCi/ml [3H]inositol for 1 h. Cells were
washed three times with buffer and incubated at 37°C. Aliquots
of extracellular medium were periodically removed and radioac-
tivity was determined. Cells were then washed three times with
ice-cold buffer and lysed with trichloroacetic acid. Lysates were
centrifuged and radioactivity present in supernatants was deter-
mined. B: Long-term prelabeling of cells with [3H]inositol. NT2 or
NT2-N cells were incubated with medium containing 10 mCi/ml
[3H]inositol for 18 h. Efflux of inositol was then determined as
described in A. Data are expressed as [3H]inositol recovered in
the extracellular medium relative to [3H]inositol present initially in
the cells. Results shown are mean 6 SEM values for three
separate experiments. Where error bars are not shown, they fell
within the symbol. *Different from NT2-N cells, p , 0.05. **Dif-
ferent from NT2-N cells, p , 0.01.
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value reported for a neuron-rich tissue, the Purkinje cell
layer of cat cerebellar flocculus (;20 mM; Godfrey et
al., 1982). Nonetheless, it remains possible that the con-
centration of inositol may differ considerably among
distinct populations of neurons. For example, the con-
centration of inositol in rat cerebellar granule cells (;40
nmol/mg of protein) was,25% of that in NT2-N neu-
rons.
The high concentration of inositol in NT2-N neurons
may, in part, be accounted for by an increased rate of
inositol uptake. Stimulation of inositol uptake after dif-
ferentiation is not limited to cells of neuronal lineage and
has, for example, been reported for HL60 promyeloid
cells (Baxter et al., 1991). If the elevations in inositol
concentration in NT2-N cells that result from differenti-
ation of NT2 cells were solely dependent on the two- to
threefold increase in inositol uptake, an intracellular con-
centration of;20 mM could hypothetically be attained
within 48 h. Direct determination of [3H]inositol uptake
indicated that the activity of the transporter in NT2-N
neurons permitted the equilibration of extracellular ino-
sitol with the intracellular pool within;96 h. Despite the
differences in the capacity of inositol uptake in the pre-
cursor stem cells and differentiated neurons, the charac-
teristics of uptake (EC50, Na
1 dependence, phlorizin
inhibition, and response to hypertonic stimulation) were
essentially the same and comparable to those observed
for other cell lines (Strange et al., 1991; Wiesinger, 1991;
Batty et al., 1993; Isaacks et al., 1994). Whereas chronic
hypertonicity evoked a stimulation of inositol uptake in
both NT2 and NT2-N cells, there was no commensurate
increase in the concentration of inositol in NT2-N cells.
These data suggest that the concentration of inositol in
NT2-N neurons is maximal under isotonic conditions,
and that any increases that may occur after hypertonic
exposure are not sustained. One implication of this result
is that CNS neurons may have a limited capacity to
accumulate inositol during hypernatremic stress and that
the use of inositol for osmotic regulation may thus be
primarily characteristic of glia. Glia have previously
been reported to exhibit substantial increases in inositol
concentration in response to hypertonicity (Strange et al.,
1991; Isaacks et al., 1994).
Neuronal differentiation of NT2 cells was also accom-
panied by a decreased efflux of inositol. Inositol efflux
from both NT2 and NT2-N cells occurred over a rela-
tively prolonged time course (hours) and was unaffected
by Cl2 channel inhibitors such as niflumic acid and
4,49-diisothiocyanatostilbene-2,29-disulfonic acid (data
not shown). In contrast, inositol efflux from C6 glioma
cells (Jackson and Strange, 1993) and rat astrocyte cul-
tures (Gonza´lez et al., 1995) occurs within minutes and is
mediated by a nonselective Cl2 channel. A low rate of
efflux associated with NT2-N neurons, observed under
conditions of both acute and prolonged prelabeling with
[3H]inositol, may contribute to the high concentrations of
inositol present in these cells.
A third potential mechanism whereby inositol could
accumulate in NT2-N cells is from de novo synthesis via
cyclization of glucose 6-phosphate (Eisenberg, 1967).
Whereas inositol synthase activity could be measured in
both rat brain and testis, no activity was detected in either
NT2 or NT2-N cell lysates when assayed under the same
conditions. The absence of synthase activity from NT2-N
cells and its presence in brain is consistent with previous
immunocytochemical data localizing the enzyme primar-
ily to the vasculature (Wong et al., 1987). The activity of
inositol synthase in brain was,8% of that in testis, a
value consistent with the;5% ratios previously ob-
served for rat (Eisenberg, 1967) and bovine (Mauck et
al., 1980) tissues. Despite the relatively high activity of
inositol synthase in testis, the low concentration of ino-
sitol in this tissue (21 nmol/mg of protein) suggests that
de novo synthesis may not contribute significantly to the
maintenance of cellular inositol.
In summary, differentiated NT2-N human neurons
maintain concentrations of inositol 10 times higher than
their undifferentiated precursor cells. Enhancement of
inositol uptake and reduction of inositol efflux after
differentiation may account for this difference. Although
previous studies with neural tissues have led to the sug-
gestion that the inositol content of neurons is much less
than that of glia, the present study reports the high
concentration of inositol in a differentiated human neu-
ronal cell line. There may be a wide variation in the
constitutive inositol content among neural cell types, and
the present study cautions against generalization in this
regard.
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